Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Preclinical findings on the anti-DR5 agonist antibody LBY-135 reported by Novartis

May 7, 2007

New preclinical data on GSK-923295 reported by GSK and Cytokinetics

May 7, 2007

Preclinical activity of the novel Aurora kinase inhibitor AZD-1152 profiled at the AACR meeting

May 7, 2007

Enzon cleared to begin phase I study of PEG-SN38 in cancer

May 4, 2007

Belinostat studied with doxorubicin in new phase I/II trial for soft tissue sarcomas

May 4, 2007

TH-302 demonstrates activity in orthotopic models of cancer

May 4, 2007

Novel CDK inhibitor SCH-727965 shows broad antitumor activity in preclinical studies

May 4, 2007

Antitumor activity of novel PI3K inhibitor reported by Zentaris

May 4, 2007

Treatment begins in pivotal study of picoplatin for SCLC

May 3, 2007

Phase II trials planned for VQD-002

May 3, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026